SEC Form 4 · accession 0001127602-18-020950
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stelios Papadopoulos
Director
Period of report
Jun 12, 2018
Accepted (ET)
Jun 14, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 12, 2018 | A | 1,450 | $0.00 | A | 3,190 | D | |
| Common StockF1 | holding | — | — | — | 10,831 | I | Esperanza Holdings, LLC | |
| Common StockF2 | holding | — | — | — | 17,375 | I | Stelios Holdings, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person transferred 5,831 shares that he directly owned to Esperanza Holdings, LLC.
- F2The reporting person transferred 12,375 shares that he directly owned to Stelios Holdings, LLC.